415 related articles for article (PubMed ID: 10498892)
21. Phosphorylation of a specific cdk site in E2F-1 affects its electrophoretic mobility and promotes pRB-binding in vitro.
Peeper DS; Keblusek P; Helin K; Toebes M; van der Eb AJ; Zantema A
Oncogene; 1995 Jan; 10(1):39-48. PubMed ID: 7824278
[TBL] [Abstract][Full Text] [Related]
22. c-myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases.
Alexandrow MG; Moses HL
J Cell Biochem; 1998 Sep; 70(4):528-42. PubMed ID: 9712150
[TBL] [Abstract][Full Text] [Related]
23. Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F.
Cao L; Faha B; Dembski M; Tsai LH; Harlow E; Dyson N
Nature; 1992 Jan; 355(6356):176-9. PubMed ID: 1530885
[TBL] [Abstract][Full Text] [Related]
24. Association with E2F-1 governs intracellular trafficking and polyubiquitination of DP-1.
Magae J; Illenye S; Chang YC; Mitsui Y; Heintz NH
Oncogene; 1999 Jan; 18(3):593-605. PubMed ID: 9989809
[TBL] [Abstract][Full Text] [Related]
25. Conserved region 2 of adenovirus E1A has a function distinct from pRb binding required to prevent cell cycle arrest by p16INK4a or p27Kip1.
Alevizopoulos K; Sanchez B; Amati B
Oncogene; 2000 Apr; 19(16):2067-74. PubMed ID: 10803468
[TBL] [Abstract][Full Text] [Related]
26. K-ras modulates the cell cycle via both positive and negative regulatory pathways.
Fan J; Bertino JR
Oncogene; 1997 May; 14(21):2595-607. PubMed ID: 9191059
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional repression of the E2F-1 gene by interferon-alpha is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes.
Furukawa Y; Iwase S; Kikuchi J; Nakamura M; Yamada H; Matsuda M
Oncogene; 1999 Mar; 18(11):2003-14. PubMed ID: 10208422
[TBL] [Abstract][Full Text] [Related]
28. Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16-immortalized cells.
Pagano M; Dürst M; Joswig S; Draetta G; Jansen-Dürr P
Oncogene; 1992 Sep; 7(9):1681-6. PubMed ID: 1323816
[TBL] [Abstract][Full Text] [Related]
29. Efficient down-regulation of cyclin A-associated activity and expression in suspended primary keratinocytes requires p21(Cip1).
Hauser P; Ma L; Agrawal D; Haura E; Cress WD; Pledger WJ
Mol Cancer Res; 2004 Feb; 2(2):96-104. PubMed ID: 14985466
[TBL] [Abstract][Full Text] [Related]
30. Topoisomerase IIalpha mediates E2F-1-induced chemosensitivity and is a target for p53-mediated transcriptional repression.
Nip J; Hiebert SW
Cell Biochem Biophys; 2000; 33(2):199-207. PubMed ID: 11325040
[TBL] [Abstract][Full Text] [Related]
31. Docosahexaenoic acid, a major constituent of fish oil diets, prevents activation of cyclin-dependent kinases and S-phase entry by serum stimulation in HT-29 cells.
Chen ZY; Istfan NW
Prostaglandins Leukot Essent Fatty Acids; 2001 Jan; 64(1):67-73. PubMed ID: 11161587
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylation-dependent and -independent functions of p130 cooperate to evoke a sustained G1 block.
Hansen K; Farkas T; Lukas J; Holm K; Rönnstrand L; Bartek J
EMBO J; 2001 Feb; 20(3):422-32. PubMed ID: 11157749
[TBL] [Abstract][Full Text] [Related]
33. Functional roles of E2F in cell cycle regulation.
Fan J; Bertino JR
Oncogene; 1997 Mar; 14(10):1191-200. PubMed ID: 9121768
[TBL] [Abstract][Full Text] [Related]
34. Vitamin E succinate inhibits proliferation of BT-20 human breast cancer cells: increased binding of cyclin A negatively regulates E2F transactivation activity.
Turley JM; Ruscetti FW; Kim SJ; Fu T; Gou FV; Birchenall-Roberts MC
Cancer Res; 1997 Jul; 57(13):2668-75. PubMed ID: 9205075
[TBL] [Abstract][Full Text] [Related]
35. Tumor suppressor proteins as regulators of cell differentiation.
Li ZR; Hromchak R; Mudipalli A; Bloch A
Cancer Res; 1998 Oct; 58(19):4282-7. PubMed ID: 9766653
[TBL] [Abstract][Full Text] [Related]
36. The E2F1-3 transcription factors are essential for cellular proliferation.
Wu L; Timmers C; Maiti B; Saavedra HI; Sang L; Chong GT; Nuckolls F; Giangrande P; Wright FA; Field SJ; Greenberg ME; Orkin S; Nevins JR; Robinson ML; Leone G
Nature; 2001 Nov; 414(6862):457-62. PubMed ID: 11719808
[TBL] [Abstract][Full Text] [Related]
37. Association of Pur alpha and E2F-1 suppresses transcriptional activity of E2F-1.
Darbinian N; Gallia GL; Kundu M; Shcherbik N; Tretiakova A; Giordano A; Khalili K
Oncogene; 1999 Nov; 18(46):6398-402. PubMed ID: 10597240
[TBL] [Abstract][Full Text] [Related]
38. Differentiation of P19 EC cells leads to differential modulation of cyclin-dependent kinase activities and to changes in the cell cycle profile.
Kranenburg O; de Groot RP; Van der Eb AJ; Zantema A
Oncogene; 1995 Jan; 10(1):87-95. PubMed ID: 7824282
[TBL] [Abstract][Full Text] [Related]
39. pRB phosphorylation mutants reveal role of pRB in regulating S phase completion by a mechanism independent of E2F.
Chew YP; Ellis M; Wilkie S; Mittnacht S
Oncogene; 1998 Oct; 17(17):2177-86. PubMed ID: 9811449
[TBL] [Abstract][Full Text] [Related]
40. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
Oncogene; 1999 May; 18(21):3290-302. PubMed ID: 10359535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
